TO REPORT FRAUD CALL
0800 101 999
TOLL FREE
NDA Chairperson commissioning brand new pick-ups to re-enforce the authority's operations in apprehending unscrupulous operators
Newly acquired pick-ups to enable Inspectors of Drugs to traverse the country's terrain to reach all drug outlets
NDA Chairperson commissioning brand new pick-ups to re-enforce the authority's operations in apprehending unscrupulous operators
NDA Vision

  • 7th-10th Nov 2017

    Annual Meeting of Representatives of National Pharmacovigilance Centres participating in the WHO Programme for International Drug Monitoring

                                  Read More
About NDA
Functions of NDA
Regional Offices

The National Drug Authority (NDA) was established in 1993 by the National Drug Policy and Authority Statute which in 2000 became the National Drug Policy and Authority (NDP/A) Act, Cap. 206 of the Laws of Uganda (2000 Edition). The Act established a National Drug Policy and National Drug Authority to ensure the availability, at all times, of essential, efficacious and cost-effective drugs to theentire population of Uganda as a means of providing satisfactory healthcare and safeguarding the appropriate use of drugs.

Vision

A Uganda with safe, effective, quality medicines and health care products.

Mission

Promoting and protecting public health through the effective regulation of human, animal medicines and health care products.

Core Values
  • We care for the people of Uganda, striving for excellence in service underpinned by professionalism and fairness.
  • We take pride in what we do and we are motivated and passionate about achieving the highest standards of service.
  • We serve with integrity and are honest, transparent and accountable at all times.
  • We continuously nurture team spirit, respecting and supporting each other and working together to achieve common objectives.
  • We take advantage of new opportunities for learning and use our knowledge and skills to innovate, creating value for our clients and the public.

The functions of the Drug Authority are stated under Section 5 of the NDP/A Act, Cap. 206. These are:
  • Deal with the development and regulation of the pharmacies and drugs in the country;
  • Control the importation, exportation and sale of pharmaceuticals;
  • Control the quality of drugs;
  • Promote and control local production of essential drugs;
  • Encourage research and development of herbal medicines;
  • Establish and revise professional guidelines and disseminate information to the health professionals and the public;
  • Provide advice and guidance to the Minister and bodies concerned with drugs on the implementation of the National Drug Policy;
  • Perform any other function that is connected with the above or that may be accorded to it by law.

Secretariat office Kampala
P. O Box 23096, Kampala, Uganda
Plot 19 Lumumba Avenue (opposite TWED plaza)
Tel: (+256) 414 255665/ 347391/2 (+256) 414 255758
Email: ndaug@nda.or.ug Website: www.nda.or.ug
Central regional offices Kampala
Plot 1-2 Jinja Road
Premier Complex Building Nakawa
P. O Box 40082 Kampala
Tel: +256 312 261 584
South Western Region Office- Mbarara
House 29 Mbaguta Estates, Kamukuzi
P.O Box 1886 Mbarara, Uganda
Tel: (+256) 485 421 088
Fax: (+256) 485 421 220
South Eastern Regional Office
Plot 16 Rippon Garden Road
P.O Box 1710 Jinja
Tel/Fax (+256) 434 122 176
Eastern Region Office Tororo
Plot No: 27 Kwapa Road
P.O Box 453, Tororo – Uganda
Tel/Fax (+256) 454 445 195
Western Region Office Hoima
Muganwa Center
Plot 30 Old Tooro Road
P.O Box 192 Hoima
Tel/Fax (+256) 465 440 688
Northern Region Office
Lira Erute Road
P.O Box 235 Lira
Tel/Fax (+256) 473 420 65
West Nile Region Office- Arua
P. O Box 1034, Arua Plot. 1mt
Wati Road at Anyafio
Tel: (+256)372260087

Public Notices

Public Alert - Counterfeit Cancer Medicine (Avastin)

“National Drug Authority (NDA) informs health service providers and the public that it has impounded some unregistered and counterfeit medicines; Avastin (Bevacizumab) tablets packed in plastic jar on the market that bears the following features:

Avastin 400mg, Batch no : NC 2001 Expiry date : 02/2019”

Public Alert - Counterfeit Cancer Medicine (Sutent)

“National Drug Authority (NDA) informs health service providers and the public that it has impounded some unregistered and counterfeit medicines; Sutent (sunitinib malate) tablets packed in plastic jar on the market that bears the following features:

Sutent 12.5mg , Batch no : NC 1060 Expiry date : 02/2019”

Counterfeit Alert

“This is to inform you that there is counterfeit Postinor2 circulating on the Ugandan market with the following details.
Batch No T62788B Manufacturing date: 02/20/2016 Expiry date:02/2021
Batch no. T5934T Manufacturing date: 09/2015 Expiry date: 09/2020”

Public Notice on Medicines Labelling

“NDA informs health care providers and the general public against using imported medicines which are not labelled or translated in English. Any person involved in the sale and/or dispensing of such illegal products will be prosecuted in accordance with the Law.

Public Alert

“These are drugs disguised as cosmetics and are very harmful to your health”

News Highglights

Veterinary Drugs

TICKS AND TICK BORNE DISEASES KILLING CATTLE (COWS) IN WESTERN AND CENTRAL UGANDA DUE TO EMERGENCE OF MULTI-ACARICIDE RESISTANT TICKS

For the last six years, the country has been facing the challenge of ticks not responding to drugs aimed at killing them. Ticks cause diseases that kill the animals, reduce milk production curtail reproduction and growth of animals. National Drug Authority has been central in proposing, supporting, coordinating the campaign against ticks and...

Read More »

ECTOPARASITICIDES AND THE CHALLENGE OF TICK RESISTANCE

National Drug Authority controls the manufacture, importation, distribution and use of both human and veterinary drugs in the country. The three main concerns of veterinary drug regulation are quality, safety and efficacy (effectiveness). Veterinary drugs include acaricides which are the most important of animal drugs in terms of volumes and capital investment.

Read More...